A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study

PloS One
Amelia O CliveNick A Maskell

Abstract

Animal studies have shown Zoledronic Acid (ZA) may diminish pleural fluid accumulation and tumour bulk in malignant pleural disease (MPD). We performed a pilot study to evaluate its effects in humans. We undertook a single centre, double-blind, placebo-controlled trial in adults with MPD. Patients were randomised (1:1) to receive 2 doses of intravenous ZA or placebo, 3 weeks apart and were followed-up for 6 weeks. The co-primary outcomes were change in Visual Analogue Scale (VAS) score measured breathlessness during trial follow-up and change in the initial area under the curve (iAUC) on thoracic Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) from randomisation to week 5. Multiple secondary endpoints were also evaluated. Between January 2010 and May 2013, 30 patients were enrolled, 24 randomised and 4 withdrew after randomisation (1 withdrew consent; 3 had a clinical decline). At baseline, the ZA group were more breathless, had more advanced disease on radiology and worse quality of life than the placebo group. There was no significant difference between the groups with regards change in breathlessness (Adjusted mean difference (AMD) 4.16 (95%CI -4.7 to 13.0)) or change in DCE-MRI iAUC (AMD -15.4 (95%CI -58.1 to...Continue Reading

References

Jan 27, 1990·BMJ : British Medical Journal·J N MatthewsP Royston
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J VogelzangPaolo Paoletti
Feb 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M J Byrne, A K Nowak
Dec 1, 2004·Statistics in Medicine·Ian R White, Simon G Thompson
May 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Savita WakchoureKatri S Selander
Apr 5, 2008·American Journal of Respiratory and Critical Care Medicine·Georgios T StathopoulosIoannis Kalomenidis
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 14, 2009·The New England Journal of Medicine·Michael GnantC Marth
Apr 2, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Akihiro YasumitsuTakashi Nakano
Jul 29, 2010·British Journal of Cancer·J D VeltmanJ G J V Aerts
Jan 29, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anne S TsaoEdith M Marom
Jul 16, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Steven Chuan-Hao KaoNick Pavlakis
Oct 11, 2011·Cancer Treatment Reviews·Michael Gnant, Philippe Clézardin
Dec 6, 2011·Statistics in Medicine·Brennan C Kahan, Tim P Morris
Apr 7, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Shinya OkamotoMasatoshi Tagawa
Mar 22, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew C WinterRobert E Coleman
Aug 27, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Samuel G ArmatoMichael J Byrne

❮ Previous
Next ❯

Citations

Jul 3, 2019·Expert Opinion on Investigational Drugs·Alice GuazzelliLuciano Mutti

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging technique

Clinical Trials Mentioned

ISRCTN17030426

Software Mentioned

Sealed Envelope

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.